Ka Shing Cheung

TL;DR: ACE inhibitors/angiotensin receptor blocker were associated with a lower colorectal cancer risk in a duration-response manner and every single year increase in the drug use was associated with 5% reduction in adjusted hazard ratio risk.

TL;DR: Concurrent antibiotic use during immunotherapy was associated with higher mortality in patients with advanced HCC and the role of gut dysbiosis on responses to ICI should be examined.

TL;DR: In this paper, a case-control study of 104 patients [52 HCC and 52 non-HCC (matched with age, gender, cirrhosis and treatment duration) on ≥ 3 years entecavir (ETV) with unquantifiable HBV DNA by Cobas Taqman assay v2.0 (Roche Diagnostics; lower limit of quantification [LLOQ] 20 ǫ/mL).

TL;DR: TDF was associated with a lower HCC risk compared with ETV among patients with CHB, particularly cirrhotic patients, and specific subgroups that will benefit most from TDF were identified.

TL;DR: The UK‐PBC, GLOBE scores, Rotterdam criteria, and APRI‐r1 had good and comparable prognostic prediction values for Chinese PBC patients receiving UCDA, and were comparable in predicting adverse events.